Pfizer Covid-19 pill
Pfizer Inc (PFE.N) is in discussions with 90 countries over supply contracts for its experimental COVID-19 pill, which was shown to reduce by 89% the risk of hospitalization or death in patients at high risk of severe illness, Chief Executive Officer Albert Bourla said in an interview on Friday.
He said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc (MRK.N) has priced its oral antiviral drug candidate.
Merck's U.S. contract price for its pill molnupiriavr is around $700 for a five-day course of therapy.
Reporting By Deena Beasley Editing by Chris Reese
Qatar Airways and Virgin Australia Announce a Strategic Partnership
Qatar Museums Provides Free Online Tours, Workshops, and Storytelling Activities this May
QFA denies what is being circulated in various media about hosting the final of the 2022 CAF
PHCC Announces Temporary Jobs for FIFA World Cup Qatar 2022